Literature DB >> 9075726

Integrin binding to immobilized collagen and fibronectin stimulates the proliferation of human thyroid cells in culture.

M Vitale1, M Illario, T Di Matola, A Casamassima, G Fenzi, G Rossi.   

Abstract

The expression of integrins of the beta1 family and their possible biological effects were investigated in normal human thyroid cells in monolayer culture. The expression of beta1 and alpha(1-6) integrin subunits was determined by flow cytofluorometry with specific antibodies. Follicular cells of subconfluent monolayer cultures expressed alpha2beta1 and alpha3beta1 at high levels, while alpha1beta1 was only slightly expressed, and alpha4beta1, alpha5beta1, and alpha6beta1 were never detected. Cell attachment assays were performed in fibronectin-, type I collagen-, and laminin-coated microtiter plates. Thyroid cells, while adherent to collagen and fibronectin, showed poor attachment to laminin despite the abundance of their putative receptors alpha2beta1 and alpha3beta1. In serum-free medium, collagen and fibronectin induced cytoskeletal organization, change of cell shape from round to flat, and cell spreading. [3H]Thymidine incorporation and proliferation assays were used to evaluate the effects of collagen and fibronectin on DNA synthesis and cell growth in the absence of a change in spreading or cell shape. Both substrates, in low serum-containing medium, induced a concentration-dependent increase in [3H]thymidine incorporation partially inhibited by RGD-containing peptides that blocked the cell attachment. Thyrocytes cultured in low serum-containing medium on immobilized fibronectin or collagen showed a dose-dependent stimulation of proliferation. These data indicate that fibronectin and collagen can regulate the cytoskeletal organization and cell shape and stimulate the proliferation of normal human thyroid cells in culture and that integrins mediate these effects of extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075726     DOI: 10.1210/endo.138.4.5052

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  High doses of laser phototherapy can increase proliferation in melanoma stromal connective tissue.

Authors:  Lúcio Frigo; Joseli Maria Cordeiro; Giovani Marino Favero; Durnavei Augusto Maria; Ernesto Cesar Pinto Leal-Junior; Jon Joensen; Jan Magnus Bjordal; Denise Carvalho Roxo; Rodrigo Labat Marcos; Rodrigo Alvaro Brandão Lopes-Martins
Journal:  Lasers Med Sci       Date:  2018-04-05       Impact factor: 3.161

2.  Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen.

Authors:  Steven J Wall; Erica Werner; Zena Werb; Yves A DeClerck
Journal:  J Biol Chem       Date:  2005-09-26       Impact factor: 5.157

3.  Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells.

Authors:  E Russo; M Salzano; L Postiglione; A Guerra; V Marotta; M Vitale
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 4.256

4.  Profilin1 facilitates staurosporine-triggered apoptosis by stabilizing the integrin β1-actin complex in breast cancer cells.

Authors:  Wantong Yao; Xianjun Yu; Zhengyu Fang; Peng Yin; Chao Zhao; Na Li; Liying Wang; Zengxia Li; Xiliang Zha
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

5.  Recombinant mussel proximal thread matrix protein promotes osteoblast cell adhesion and proliferation.

Authors:  Hee Young Yoo; Young Hoon Song; Mathias Foo; Eunseok Seo; Dong Soo Hwang; Jeong Hyun Seo
Journal:  BMC Biotechnol       Date:  2016-02-16       Impact factor: 2.563

6.  Effect of manufacturing and experimental conditions on the mechanical and surface properties of silicone elastomer scaffolds used in endothelial mechanobiological studies.

Authors:  Marc-Antoine Campeau; Audrey Lortie; Pierrick Tremblay; Marc-Olivier Béliveau; Dominic Dubé; Ève Langelier; Léonie Rouleau
Journal:  Biomed Eng Online       Date:  2017-07-14       Impact factor: 2.819

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.